ACEA BIOSCIENCES, INC.

ACEA BIOSCIENCES, INC. specializes in the repair, maintenance, and manufacturing of precision electronic and analytical laboratory instrumentation, with a demonstrated focus on complex biomedical equipment. The company provides extended warranty services and comprehensive service agreements for high-sensitivity devices, including flow cytometers, ensuring operational continuity and regulatory compliance in mission-critical environments. Their technical expertise lies in the calibration, diagnostics, and preventive maintenance of analytical laboratory instruments, with deep familiarity in post-warranty service protocols, firmware updates, and component-level repairs that preserve instrument accuracy and data integrity. This specialization positions them as a trusted partner for laboratories requiring uninterrupted performance of sophisticated detection systems. The contractor maintains a consistent relationship with the Department of Health and Human Services, delivering critical support services for instrumentation used in public health research, clinical diagnostics, and biomedical analysis. Their engagements reflect a pattern of long-term service partnerships, where reliability and technical precision are paramount to sustaining federal health initiatives. ACEA BIOSCIENCES operates primarily within NAICS 811219 (electronic equipment repair and maintenance) and 334516 (analytical laboratory instrument manufacturing), focusing on the lifecycle support of high-end scientific hardware. Their market positioning centers on bridging the gap between equipment manufacturers and end-user laboratories by offering specialized, manufacturer-authorized service capabilities that extend instrument lifespan and performance. The company’s entity structure, certifications, and geographic presence are not disclosed in available records. While no formal government certifications are listed, their contract history indicates direct engagement with federal health agencies under strict service-level expectations, suggesting adherence to quality and compliance standards inherent in public sector biomedical procurement.